Infant Formula Made in America Act of 2025
- Sponsor
- Rep. Nunn, Zachary [R-IA-3]
- Committees
- Ways and Means Committee (primary)
- Last action
- Mar 10, 2025
Bottom line
The bill incentivizes domestic infant formula manufacturing through targeted tax credits for smaller producers, aiming to enhance supply chain resilience and reduce reliance on foreign sources.
What it actually does
This bill amends the Internal Revenue Code of 1986 to establish two new tax credits aimed at boosting domestic infant formula production. It creates a 30% investment tax credit for eligible smaller manufacturers to re-equip, expand, or establish facilities, capped at $750 million in total credits. Additionally, it introduces a $2 per pound production tax credit for eligible smaller manufacturers, limited to 18 million pounds annually for a maximum of five years, with a crucial caveat that facilities receiving the investment credit cannot also claim the production credit.
Proponents argue
Supporters argue that this bill is a critical step to prevent future infant formula shortages by strengthening the domestic supply chain and reducing reliance on foreign manufacturers. They contend that the targeted credits for smaller producers will foster competition, create jobs, and ensure a more stable and secure supply of essential nutrition for infants, learning from past supply chain vulnerabilities.
Opponents contend
Critics might argue that while the goal is laudable, tax credits can be an inefficient and costly way to achieve policy goals, potentially leading to market distortions or corporate welfare. They may also contend that the revenue caps could exclude larger, more established domestic producers who might be better positioned to quickly scale production, thus limiting the overall effectiveness of the intervention.
The bill is relatively short and clearly structured, making it accessible for an informed reader to understand its core provisions within a reasonable timeframe.
Section 2, new Internal Revenue Code Section 48F
Domestic Infant Formula Manufacturing Investment Credit
This provision establishes a new 30% investment tax credit for eligible taxpayers who invest in projects to re-equip, expand, or establish facilities for manufacturing eligible infant formula in the United States. To qualify, a taxpayer's global revenue in the preceding year must not exceed $750 million. The credit is capped at $150 million per project and $750 million in total aggregate credits, with a sunset clause for projects commencing construction 10 years after enactment. Recipients must certify that at least 50% of the formula produced will be sold for use in the United States, and there are recapture provisions if these requirements are not met within a one-year period.
Supporters argue
Proponents argue that this investment credit is crucial for incentivizing the capital expenditure needed to build and upgrade domestic infant formula production capacity. They highlight the revenue cap as a way to support emerging or smaller manufacturers, fostering a more diverse and resilient supply chain rather than relying solely on a few large players. The 50% domestic sales requirement ensures the benefits directly address U.S. supply needs.
Critics contend
Opponents might contend that a 30% investment credit could lead to over-investment or inefficient allocation of capital in the sector. They may also question the effectiveness of the one-year recapture period for ensuring long-term commitment to domestic sales, suggesting it might be too short to deter companies from shifting focus after receiving the credit.
Tradeoffs
The provision balances the need to incentivize domestic manufacturing with concerns about market distortion and fiscal cost. The revenue cap aims to support smaller businesses, but this might exclude larger, potentially more efficient producers. The recapture mechanism seeks to ensure compliance with domestic sales requirements, but its short duration presents a tension between enforcement and flexibility for businesses.
Section 3, new Internal Revenue Code Section 45BB
Infant Formula Production Credit
This provision establishes a new production tax credit of $2 per pound for eligible infant formula manufactured and sold for use in the United States. Similar to the investment credit, a 'qualified taxpayer' must have global revenue not exceeding $750 million in the preceding taxable year, or have received the credit in the prior year. The credit is limited to 18 million pounds of formula per year per taxpayer and can only be claimed for a maximum of five taxable years. Importantly, formula produced at a facility that received the Section 48F investment credit is explicitly excluded from this production credit.
This subsection explicitly states that infant formula produced at a facility that received the Section 48F investment credit shall not be taken into account for the Section 45BB production credit.
Section 3(f) (Coordination With Investment Credit)
Why it matters:This is standard legislative practice to prevent taxpayers from claiming multiple credits for the same activity, ensuring that the incentives are distinct and not cumulative for the same production line.
Case for: Ensures fiscal responsibility by preventing 'double-dipping' and encourages manufacturers to strategically choose the most appropriate incentive for their business model, either capital investment or ongoing production.
Case against: Some might argue that allowing both credits could provide a stronger, more comprehensive incentive for domestic production, especially for new entrants facing both high capital costs and initial production hurdles.
Estimated impact: Prevents potentially millions of dollars in additional tax expenditures by ensuring that a single manufacturing activity does not benefit from both major incentives simultaneously.
Both the investment credit and the production credit define 'eligible taxpayer' or 'qualified taxpayer' as having total global revenue for the preceding calendar/taxable year not exceeding $750,000,000.
Section 2(c)(1)(A) and Section 3(b)(1)
Why it matters:This is a deliberate policy choice embedded in the definitions to target the incentives towards smaller or mid-sized companies, rather than the largest multinational corporations, which is a common legislative technique.
Case for: Proponents argue this cap ensures the credits benefit smaller, potentially more agile domestic producers, fostering competition and reducing reliance on a few dominant players. It prevents large corporations from using the credits to further consolidate market share.
Case against: Critics might argue that this cap excludes major existing domestic producers who could rapidly scale up production, potentially limiting the overall impact on supply chain resilience. They might suggest that focusing solely on smaller players could be less efficient in achieving large-scale production increases.
Estimated impact: Significantly narrows the pool of potential beneficiaries for both tax credits, directing federal support towards a specific segment of the infant formula manufacturing industry.
The recapture period for the domestic infant formula manufacturing investment credit is defined as the '1-year period beginning on the date on which a qualifying infant formula manufacturing project... is placed in service.'
Section 2(e)(3) (Recapture period)
Why it matters:This is a technical detail related to compliance and enforcement, typically placed in such subsections. The brevity of the period, however, is a substantive policy choice.
Case for: Proponents might argue that a one-year recapture period provides sufficient time to ensure initial compliance with the domestic sales requirement without imposing an overly burdensome long-term obligation on businesses, allowing for flexibility after the initial ramp-up.
Case against: Critics could contend that a one-year recapture period is too short to ensure long-term commitment to the bill's goals, such as sustained domestic supply and reduced reliance on foreign sources. They might argue it allows companies to potentially benefit from the credit and then shift production or sales focus shortly thereafter without significant penalty.
Estimated impact: Limits the duration of the government's ability to claw back the investment credit if the domestic sales requirement is not met, potentially reducing the long-term enforcement leverage.